Here's a good example of the advantage of being early in biotech.
Before Moderna went public in 2018, it had no products on the market.
It was a microcap focused on the once-obscure niche of messenger RNA products…
And its share price stayed well below $30 during its first year of trading.
But once news leaked that its COVID vaccine would win FDA approval in Dec. 2020…
The stock went on a tear from $29 in March 2020 to $450 in September 2021.
And folks who bought at $29 and sold at $450 made over 15x profits that period.
Of course, the rally was driven by the worldwide vaccination against COVID-19…
The world has moved on, and the Moderna stock now sits at $118.
Still, the one thing you'll notice is the clear advantage of being early.
If you bought at $50, you didn't profit as much as the guy who bought at $29.
The trick is knowing the best time to get in and out for maximum returns and…
One proven way to get your timing right is to follow the paper trail of insiders.
See our approach in this episode of Insiders Exposed.
To your trading success.
Steve Place
| | | In Case You Missed It
1. Every time I do this, I lose money
2. They are weaponizing energy
3. When to leverage "institutional capital"
| | |
|
|
|
No comments:
Post a Comment